September 2018

Project CBD, a California-based educational non-profit, has published an in-depth Primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report, summarized below, is available for free download at the bottom of the page. Drug interactions are a significant consideration in modern medicine. More than half of U.S. adults regularly take prescription meds […]

by

There has been quite a lot of big news coming out involving cannabis as of late, with much of this news being in regard to clinical trials and government approvals. All of these clinical trials are helping to further our knowledge of cannabis’s potential medical benefits and safety as a medication, and they are opening […]

by

The faces of Dravet Syndrome.What Does the Ruling Mean for Most School Districts Nationwide? It appears that many individual school districts, especially in medical marijuana-approved states, will now be forced to suddenly begin the evaluation process of whether districts will have to allow the new prescription pharmaceutical to be used on school grounds and buses. […]

by

Project CBD, a California-based educational non-profit, has published an in-depth Primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report, summarized below, is available for free download at the bottom of the page. Drug interactions are a significant consideration in modern medicine. More than half of U.S. adults regularly take prescription meds […]

by

Treatment with EHP-102, an investigational cannabinoid-derived medicine, reduced weight loss, preserved motor neurons of the spinal cord, and lowered the abnormal reactivity of astroglial cells in a mouse model of amyotrophic lateral sclerosis (ALS), new research shows. Findings were recently published in the study, “Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an […]

by

Most epilepsy patients taking cannabis-derived oil in a clinical trial at the University of Nebraska Medical Center continue to see improvement in their seizures. The study, authorized by Nebraska lawmakers in 2015, showed that the majority of the 23 participating patients have experienced benefits from taking cannabidiol, commonly referred to as CBD oil. The Legislature […]

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://www.newspressnow.com/news/national/majority-of-epilepsy-patients-in-unmc-cannabidiol-trial-have-seen/article_02eddc6a-3846-5cc0-b594-b23775308c86.html

by

PALM BEACH, Florida, September 20, 2018 /PRNewswire/ — MarketNewsUpdates.com News Commentary  Personal Care and Healthcare products infused with cannabidiol (CBD) are rapidly becoming the product du jour. Derived from the hemp plant, a cousin to marijuana, CBD boasts a number of health and skin benefits because of its rich in fatty acids and natural emollients. […]

by

The U.S. Drug Enforcement Agency granted approval to Canada-based Tilray Inc. to import research-grade marijuana products for a clinical trial at the University of California, San Diego. Tilray will provide cannabinoids for a study on essential tremor, a neurological movement disorder characterized by involuntary and rhythmic shaking. The clinical trial, which will start in 2019, […]

by

LINCOLN — Most patients with severe epilepsy who’ve been taking a marijuana-derived drug through the University of Nebraska Medical Center continue to see improvement in their seizures. A majority of the 23 patients who’ve remained in a two-year clinical trial have experienced fewer or less-severe seizures while taking purified cannabidiol, or CBD oil, a UNMC […]

by